Tongji J. Xie
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100144, China
Beijing, 100144, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Surgical designs and clinical effects of pedicled transfer of extended lower trapezius musculocutaneous flap in repairing massive wounds in the shoulder and back
Journal: Zhonghua shao shang yu chuang mian xiu fu za zhi
Published: September 07, 2026
Biomarker exploration for immunotherapy plus chemotherapy following resistance to third-generation EGFR-TKIs in lung adenocarcinoma.
Journal: BMC cancer
Published: February 18, 2026
Mechanisms and therapeutic targets in distant metastasis of lung adenocarcinoma.
Journal: Signal transduction and targeted therapy
Published: October 18, 2025
Multiomic characterization of malignant pulmonary nodules and development of a methylation-based diagnostic Model.
Journal: Journal of translational medicine
Published: August 20, 2025
Digital spatial profiling uncovers transcriptomic features of distinct plasma cell-like phenotypes in diffuse large B-cell lymphoma.
Journal: Blood advances
Published: August 18, 2025
DSG2+ Cancer Stem Cells Co-Located With FAP+ Myofibroblasts in the Tumor Boundary That Determines the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 31, 2025
Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancer.
Journal: NPJ precision oncology
Published: July 17, 2025
Rituximab combined with intensive immunochemotherapy for sporadic adult Burkitt lymphoma: efficacy and prognosis analyse
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: March 26, 2025
A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma.
Journal: Experimental hematology & oncology
Published: December 02, 2024
Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study.
Journal: Cancer immunology, immunotherapy : CII
Published: September 26, 2024
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: August 27, 2024
Last Updated: 09/26/2026